Clearmind Medicine (CMND) Return on Invested Capital (2023 - 2026)
Clearmind Medicine (CMND) posted quarterly Return on Invested Capital of 0.05% for Q2 2026, down 2.0% year-over-year from 0.06% in Q2 2025, and down 53.12% quarter-over-quarter from 0.04% in Q1 2026.
Clearmind Medicine (CMND) Return on Invested Capital (2023 - 2026) Analysis & Trends
Clearmind Medicine's Return on Invested Capital history runs 4 years deep, the most recent figure standing at 0.05% for Q2 2026.
- In Q2 2026, Return on Invested Capital fell 2.0% year-over-year to 0.05%; the TTM figure through Apr 2026 stood at 0.05% (down 2.0% YoY), while the FY2025 annual figure was 0.11%, up 6.0% from the prior year.
- Return on Invested Capital for Q2 2026 stood at 0.05%, down from 0.04% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.02% in Q4 2025, with the low at 0.08% in Q3 2024.
- The 4-year median for Return on Invested Capital is 0.04% (2024), against an average of 0.05%.
- The sharpest annual moves came in 2025 and 2026: Return on Invested Capital increased 6 bps in 2025, then declined 2 bps in 2026.
- Clearmind Medicine's Return on Invested Capital stood at 0.05% in 2023, then grew by 16 bps to 0.04% in 2024, then soared by 64 bps to 0.02% in 2025, then tumbled by 248 bps to 0.05% in 2026.
- Business Quant data shows CMND's Return on Invested Capital at 0.05% in Q2 2026, 0.04% in Q1 2026, and 0.02% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.17% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Clearmind Medicine | 537,435.54 | -13.06 Mn | - | -0.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -0.05% |
| Jan 31, 2026 | -0.04% |
| Oct 31, 2025 | -0.02% |
| Jul 31, 2025 | -0.02% |
| Apr 30, 2025 | -0.03% |
| Jan 31, 2025 | -0.04% |
| Oct 31, 2024 | -0.04% |
| Jul 31, 2024 | -0.08% |
| Apr 30, 2024 | -0.07% |
| Jan 31, 2024 | -0.08% |
| Oct 31, 2023 | -0.05% |